دورية أكاديمية
Non-alcoholic fatty liver disease: A patient guideline
| العنوان: | Non-alcoholic fatty liver disease: A patient guideline |
|---|---|
| المؤلفون: | Francque, Sven M, Marchesini, Giulio, Kautz, Achim, Walmsley, Martine, Dorner, Rebecca, Lazarus, Jeffrey V, Zelber-Sagi, Shira, Hallsworth, Kate, Busetto, Luca, Frühbeck, Gema, Dicker, Dror, Woodward, Euan, Korenjak, Marko, Willemse, José, Koek, Gerardus H, Vinker, Shlomo, Ungan, Mehmet, Mendive, Juan M, Lionis, Christos |
| المساهمون: | Francque, Sven M, Marchesini, Giulio, Kautz, Achim, Walmsley, Martine, Dorner, Rebecca, Lazarus, Jeffrey V, Zelber-Sagi, Shira, Hallsworth, Kate, Busetto, Luca, Frühbeck, Gema, Dicker, Dror, Woodward, Euan, Korenjak, Marko, Willemse, José, Koek, Gerardus H, Vinker, Shlomo, Ungan, Mehmet, Mendive, Juan M, Lionis, Christos |
| سنة النشر: | 2021 |
| المجموعة: | IRIS Università degli Studi di Bologna (CRIS - Current Research Information System) |
| مصطلحات موضوعية: | ALD, alcohol-related or alcoholic liver disease, ASH, alcoholic steatohepatiti, BMI, body mass index, CAP, controlled attenuation parameter, CT, computed tomography, CVD, cardiovascular disease, EASD, European Association for the Study of Diabete, EASL, European Association for the Study of the Liver, EASO, European Association for the Study of Obesity, FIB-4, fibrosis-4 index, FXR, farnesoid X receptor, GLP-1 RAs, glucagon-like receptor 1 agonist, GP, general practitioner, HCC, hepatocellular carcinoma, HDL, high-density lipoprotein |
| الوصف: | This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which has an important impact on the information that is given (or not) to patients. Its management requires a close interaction between patients and their many healthcare providers. It is important for patients to develop a full understanding of NAFLD in order to enable them to take an active role in their disease management. This guide summarises the current knowledge relevant to NAFLD and its management. It has been developed by patients, patient representatives, clinicians and scientists and is based on current scientific recommendations, intended to support patients in making informed decisions. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | ELETTRONICO |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/34693236; info:eu-repo/semantics/altIdentifier/wos/WOS:000706949300003; volume:3; issue:5; firstpage:100322; lastpage:100322; numberofpages:39; journal:JHEP REPORTS; http://hdl.handle.net/11585/839578Test; https://www.ncbi.nlm.nih.gov/pubmed/34693236Test |
| DOI: | 10.1016/j.jhepr.2021.100322 |
| الإتاحة: | https://doi.org/10.1016/j.jhepr.2021.100322Test http://hdl.handle.net/11585/839578Test https://www.ncbi.nlm.nih.gov/pubmed/34693236Test |
| رقم الانضمام: | edsbas.2CADC785 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.jhepr.2021.100322 |
|---|